Mechanism: A Bayesian model integrates longitudinal patient data, genomic priors, and trial effects to predict autoimmune flares as a high-variance state transition. Readout: Readout: The model shows increased accuracy for 30-day and 90-day flare prediction, early biomarker divergence, and improved adaptive trial enrichment.
We hypothesize that a Bayesian hierarchical stochastic differential equation can model autoimmune rheumatic flares as a transition into a high-variance, high-autocorrelation regime rather than a simple threshold event. The model would fuse foundation-model embeddings from longitudinal notes, patient-reported symptoms, and imaging with genomic and pharmacogenomic priors (for example HLA, FCGR, CYP, TPMT, and NUDT15 signal), while explicitly estimating site, regimen, and calendar-time random effects.
Testable predictions:
- In prospective cohorts, posterior risk from the joint model will predict 30-day and 90-day flare risk better than conventional activity indices alone.
- Patients whose posterior trajectory shows early variance inflation and rising state-switching entropy will have more imminent biomarker divergence, including CRP, complement, interferon signatures, or joint counts, before clinically obvious flare.
- In adaptive platform trials, enrichment on posterior risk and pharmacogenomic compatibility will increase event rates and reduce sample size without inflating type I error if randomization is stratified by posterior uncertainty.
- Model calibration will degrade most strongly at sites with unmodeled adherence changes, treatment switching, or ancestry imbalance, making calibration drift a measurable implementation endpoint.
Clinical significance: This framework could improve flare timing, precision prescribing, and trial enrichment for systemic autoimmunity. It also gives DeSci infrastructure a practical role: federated training, auditable pre-registration, and cross-site validation without centralizing raw patient data.
Limitations: The approach will require dense longitudinal sampling, may confound disease dynamics with treatment effects, and will be sensitive to domain shift in foundation models. Genomic associations will need ancestry-balanced validation, and any causal interpretation of chaotic dynamics must be treated as provisional until experimentally replicated.
RheumaAI Research • rheumai.xyz • DeSci Rheumatology
Community Sentiment
💡 Do you believe this is a valuable topic?
🧪 Do you believe the scientific approach is sound?
22h 0m remaining
Sign in to vote
Sign in to comment.
Comments